Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Virginia Commonwealth University National Center on Minority Health and Health Disparities (NCMHD) |
---|---|
Information provided by: | Virginia Commonwealth University |
ClinicalTrials.gov Identifier: | NCT00619320 |
This study will examine safer sex skills building (SSB), a targeted behavioral HIV prevention and risk reduction group intervention in two samples of pregnant drug abusing women.
Condition | Intervention | Phase |
---|---|---|
HIV Infections Substance Use |
Behavioral: Safer Sex Skills Building (SSB) |
Phase II Phase III |
Study Type: | Interventional |
Study Design: | Prevention, Randomized, Open Label, Parallel Assignment, Efficacy Study |
Official Title: | Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women |
Estimated Enrollment: | 400 |
Study Start Date: | December 2008 |
Estimated Study Completion Date: | October 2012 |
Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
5 group session Safer Sex Skill Building Intervention focused on HIV/STD prevention and safer sex negotiation skills
|
Behavioral: Safer Sex Skills Building (SSB)
Test the effectiveness of an intervention for reducing sexual risk factors for HIV infection in two samples of pregnant drug-using women. The intervention, Safer Sex Skills Building (SSB)(El Bassel and Schilling (1991, 1992)), is a manual-driven, gender-specific group intervention delivered by mental health counselors. To date, its effectiveness has not been examined in pregnant, drug using women. The proposed study will examine the effectiveness of the intervention in both drug treatment (RBHA, N = 200) and prenatal care (PCC, N = 200) settings. Using a randomized clinical trial design, the study will compare the five-session SSB group intervention to a one-session standard group HIV Education session (ED). Study hypotheses: that women in the SSB intervention will have better outcomes (e.g., fewer unprotected penetrative sexual behaviors) than women in the control group (ED).
|
2: Active Comparator
one group session focused on standard HIV/STD education
|
Behavioral: Safer Sex Skills Building (SSB)
Test the effectiveness of an intervention for reducing sexual risk factors for HIV infection in two samples of pregnant drug-using women. The intervention, Safer Sex Skills Building (SSB)(El Bassel and Schilling (1991, 1992)), is a manual-driven, gender-specific group intervention delivered by mental health counselors. To date, its effectiveness has not been examined in pregnant, drug using women. The proposed study will examine the effectiveness of the intervention in both drug treatment (RBHA, N = 200) and prenatal care (PCC, N = 200) settings. Using a randomized clinical trial design, the study will compare the five-session SSB group intervention to a one-session standard group HIV Education session (ED). Study hypotheses: that women in the SSB intervention will have better outcomes (e.g., fewer unprotected penetrative sexual behaviors) than women in the control group (ED).
|
"Safer Sex Skills Building" in Pregnant Women: Dace Svikis, (Psychology, Ob-Gyn, Psychiatry) PI, Diane Langhorst (Social Work) and Nichole Karjane, (OB-Gyn) Co-Investigators). This study will focus on increasing Safer Sex Skills development among pregnant women at high risk for HIV infection. The "Safer Sex Skill Building" (SSB) program developed by El Bassel and Schilling (1991, 1992), has demonstrated efficacy in national studies in reducing sexual risk for HIV and other STD transmission. This manual-driven, gender-specific intervention has proven effective in reducing sexual risk behaviors in both methadone maintenance and outpatient drug-free patients. To date, however, the intervention has not been tested with pregnant drug abusing women who may actually be at increased risk if they stop using condoms or continue drug use during pregnancy. This study will examine SSB, a targeted behavioral HIV prevention and risk reduction intervention in two samples of pregnant drug abusing women. Using a 2x2 design, a randomized clinical trial will compare the five-session SSB group intervention to a one-session standard group HIV Education intervention (SE). Study findings will provide benchmark data on the efficacy of SSB for HIV and STD prevention in a diverse sample of pregnant drug abusing women.
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Both sites:
Contact: Diane M Langhorst, Ph.D. | 804-827-2524 | dlanghorst@vcu.edu |
Contact: Danielle Terrell, BS | 804-827-1153 | dterrell@vcu.edu |
United States, Virginia | |
Virginia Commonwealth University, Nelson Womens Health (OB) Clinic | |
Richmond, Virginia, United States, 23298 | |
Richmond Behavioral Health Authority (RBHA) | |
Richmond, Virginia, United States, 23219 |
Principal Investigator: | Dace S Svikis, Ph.D. | Professor, Department of Psychology, Virginia Commonwealth University |
Responsible Party: | Virginia Commonwealth Iniversity ( Dace Svikis, Ph.D., Professor of Psychology ) |
Study ID Numbers: | P60MD002256 (Project 2 15378) |
Study First Received: | February 6, 2008 |
Last Updated: | October 22, 2008 |
ClinicalTrials.gov Identifier: | NCT00619320 History of Changes |
Health Authority: | United States: Institutional Review Board |
HIV primary prevention Health promotion Health behavior Risk reduction behavior Sexual behavior |
Safe sex Women's health Minority health Pregnant Women HIV seronegativity |
Virus Diseases Sexually Transmitted Diseases, Viral HIV Infections Sexually Transmitted Diseases |
Acquired Immunodeficiency Syndrome Retroviridae Infections Immunologic Deficiency Syndromes |
Virus Diseases Sexually Transmitted Diseases, Viral RNA Virus Infections Slow Virus Diseases Immune System Diseases HIV Infections |
Sexually Transmitted Diseases Acquired Immunodeficiency Syndrome Lentivirus Infections Infection Retroviridae Infections Immunologic Deficiency Syndromes |